SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
SC TO-T/A

Amendment to a previously filed SC TO-T

Mergers & Acquisitions
View HTML
SC TO-T/A

Amendment to a previously filed SC TO-T

Mergers & Acquisitions
View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

3,4,5
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML
SC 13D/A

An amendment to a SC 13D filing

Other
View HTML

Data provided by Kaleidoscope.